Clinical study for analyzing the SUV threshold value of the regions of interest containing the range of reactive morphological cells containing tumor cells through C11-Acetate PET in brain tumor patients.
Not Applicable
Recruiting
- Conditions
- Neoplasms
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Adult men and women aged 20 and above
Patients with newly diagnosed primary brain tumors
Brain tumors that show enhancement in MRI and are similar in appearance to the characteristic shape of glioblastoma.
Exclusion Criteria
Patients who have received chemotherapy or radiation therapy as previous treatments
Cases where the participant is unable to read the consent form (e.g., illiteracy, foreigners, etc.)
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study aims to analyze the tissues that show C11-Acetate uptake during brain tumor surgery, determine the range of reactive astrocytes containing tumor cells according to the degree of C11-Acetate uptake, and establish the most ideal cutoff for Acetate uptake for this purpose.
- Secondary Outcome Measures
Name Time Method The volume of C11-Acetate uptake and the prognosis of the patient.